2025年5月25日 周日
Home > Archive>Volume 30, Issue 3, 2022 >260-264
PDF HTML XML Export Cite reminder
Diagnostic value and prospect of MBF and CFR measured by radionuclide myocardial imaging in coronary heart disease
Author:
Affiliation:

Nuclear Medicine Department, People's Hospital of Liaoning Provincial, Shenyang, Liaoning 110000, China)

Clc Number:

R5

  • Article
    • | |
  • Metrics
    • |
  • Reference
    • |
  • Related
    • |
  • Cited by
    • | |
  • Comments
    Abstract:

    Cardiovascular disease is the leading cause of death in the world. The economic cost of treatment and diagnosis is very high. In the past two decades, the diagnosis, treatment and evaluation of patients with coronary heart disease have undergone various changes. Positron emission tomography is a powerful and multi-functional noninvasive imaging examination, especially by quantifying the myocardial blood flow and coronary flow reserve, it can better describe the characteristics of coronary artery disease, play an important role in the early diagnosis, classification and treatment of coronary microvascular disease and ischemic cardiomyopathy.

    Reference
    Related
    Cited by
Get Citation

HAN Mengyue, XIE Feng, ZHU Fang, WU Tianhui, ZI Jinping, ZHOU Jinhui, CHEN Baiqing, WANG Wenjia. Diagnostic value and prospect of MBF and CFR measured by radionuclide myocardial imaging in coronary heart disease[J]. Editorial Office of Chinese Journal of Arteriosclerosis,2022,30(3):260-264.

Copy
Share
Article Metrics
  • Abstract:
  • PDF:
  • HTML:
  • Cited by:
History
  • Received:October 24,2020
  • Revised:March 16,2021
  • Online: January 14,2022
Article QR Code

You are the 48817 visitor

Post Code：421001 Fax：0734-8160523

Phone：0734-8160765 E-mail：dmzzbjb@163.net

Editorial Office of Chinese Journal of Arteriosclerosis ® 2025